SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (50723)2/6/2019 11:50:11 AM
From: XenaLives  Read Replies (1) | Respond to of 52153
 
That is interesting - I've learned more about this since owning Anavex stock - they were studying the microbiome in their P2 safety trial for Alzheimer's. It's clear that their trials are about more than getting a passing grade - they are advancing CNS science too.

I believe that 21st century medicine is about to become a reality.



To: Biomaven who wrote (50723)2/11/2019 10:19:26 AM
From: nigel bates  Respond to of 52153
 
The role of the gut virome appears to be even less well understood:

ncbi.nlm.nih.gov